Pediarix®: Clinical Trials

4 trials of Pediarix®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Pediarix®: new trials by email Literature Review of Pediarix® trials Research Report on Pediarix®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age
Hib-MenCY-TT (MenHibrix®), Pediarix®, Rotarix® - Neisseria Meningitidis, Haemophilus Influenzae Type b
Phase 3CompletedGlaxoSmithKline6002014-02-012018-09-14
Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines
Pentacel® (DTaP-IPV/Hib), Other Pertussis Vaccines - Pertussis
CompletedSanofi Pasteur, a Sanofi Company11952010-02-082022-04-25
Database Surveillance Safety Study of PENTACEL® Vaccine
DTaP-IPV/Hib, Other DTap Vaccines - Diphtheria, Tetanus
CompletedSanofi Pasteur, a Sanofi Company625382008-09-012015-08-19
Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix), GSK Biologicals' Hib-meningococcal vaccine GSK 792014 (Menhibrix), Infanrix® - Infections, Meningococcal
Phase 3CompletedGlaxoSmithKline15582008-02-132018-09-21

Conditions studied

Haemophilus Infections (2)  ·  Whooping Cough (2)  ·  Diphtheria (1)  ·  Meningococcal Infections (1)  ·  Tetanus (1)

Sponsors

GlaxoSmithKline (2)  ·  Sanofi Pasteur, a Sanofi Company (2)

Countries

United States (4)

Results publications

PMID 25152325, PMID 25156560, PMID 25305567, PMID 27373595, PMID 32921507